Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Hoth outlines progress within COVID-19 pipeline

Nov. 5, 2020

Aligos begins first-in-human trial of ALG-000184 for chronic hepatitis B

Nov. 4, 2020

AT-752 improves survival in mouse model of dengue infection

Nov. 4, 2020

Innovation Pharmaceuticals receives pre-IND response for brilacidin trial in COVID-19

Nov. 4, 2020

Senhwa submits IND for phase II trial of silmitasertib for severe COVID-19

Nov. 3, 2020

FDA clears initiation of phase III trial of itolizumab in COVID-19 patients with ARDS

Nov. 3, 2020

Second-generation anti-HCV cyclophilin inhibitor with reduced immunosuppressive activity

Nov. 3, 2020

Enanta Pharmaceuticals divulges new antivirals

Nov. 3, 2020

FDA clears IND application for phase I study of CORVax12 vaccine candidate for COVID-19

Nov. 3, 2020

IDMC recommends modification of REGN-COV2 trial in hospitalized COVID-19 patients

Nov. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...